Provided by Tiger Trade Technology Pte. Ltd.

IDEXX Laboratories

554.99
+9.911.82%
Post-market: 554.990.00000.00%19:30 EDT
Volume:340.99K
Turnover:188.65M
Market Cap:43.78B
PE:39.00
High:556.01
Open:547.81
Low:545.48
Close:545.08
52wk High:769.98
52wk Low:518.55
Shares:78.88M
Float Shares:78.57M
Volume Ratio:0.87
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.23
EPS(LYR):13.08
ROE:74.21%
ROA:27.08%
PB:27.15
PE(LYR):42.43

Loading ...

Bank of America Securities Reaffirms Their Hold Rating on Idexx Laboratories (IDXX)

TIPRANKS
·
Apr 08

Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and Idexx Laboratories (IDXX)

TIPRANKS
·
Apr 07

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 07

Revvity Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 03

Idexx Laboratories' Cancer Dx Panel for Canine Lymphoma Early Detection Available in the UK

MT Newswires Live
·
Apr 01

IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

THOMSON REUTERS
·
Apr 01

Revvity Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 01

Stifel Nicolaus Adjusts IDEXX Laboratories PT to $675 From $775, Maintains Buy Rating

MT Newswires Live
·
Mar 31

IDEXX Laboratories Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 28

Is It Time To Reassess IDEXX Laboratories (IDXX) After Its Strong 1 Year Share Price Run?

Simply Wall St.
·
Mar 28

IDEXX Laboratories names April 13, 2026 exit for EVP Nimrata Hunt; separation benefits total $2.3 million

Reuters
·
Mar 26

IDEXX Laboratories Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Mar 25

Analysts Conflicted on These Healthcare Names: Pfizer (PFE) and Idexx Laboratories (IDXX)

TIPRANKS
·
Mar 24

Revvity Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 24

Revvity Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 19

Should IDEXX’s Earnings Beat and Higher Guidance Require Action From IDEXX Laboratories (IDXX) Investors?

Simply Wall St.
·
Mar 18

Revvity Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Mar 18

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 17

Revvity Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Mar 13

Is It Too Early To Reconsider IDEXX Laboratories (IDXX) After Recent Share Price Pullback?

Simply Wall St.
·
Mar 11